Tag: Health Care

Displaying 541 - 560 of 886 results.

Pages

In a unanimous administrative opinion and order made public today, the Federal Trade Commission ruled that North Texas Specialty Physicians (NTSP), an association of independent physicians in the Forth Worth, Texas area, illegally fixed prices in its negotiations with payors, including insurance...
An amicus brief in support of plaintiffs-appellants’ petition for panel rehearing and rehearing en banc. The case concerns a decision by a divided panel of the appeals court upholding the dismissal, pursuant to FRCP 12(b)(6), of an antitrust challenge to a Hatch-Waxman patent...
Commission approval of final consent order: Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning DaVita, Inc. and Gambro AB. The Commission vote approving the final order was 4-0. (FTC File No. 051-0051, Docket No. C-4152;...
The Federal Trade Commission today filed a complaint in federal district court seeking to put an end to an agreement between drug manufacturers Galen Chemicals Ltd. (now known as Warner Chilcott) and Barr Laboratories (Barr) that is denying consumers the choice of a lower-priced generic version of...
The Commission settled with Barr Laboratories concluding its federal court action challenging an agreement between Warner Chilcott and Barr in which, the Commission alleged, Barr agreed not to sell a lower-priced generic substitute of Warner Chilcott’s branded Ovcon 35, an oral...
Evanston Northwestern Healthcare Corporation (ENH), located in Evanston, Illinois, must sell Highland Park Hospital (Highland Park) within 180 days, under the terms of an initial decision and order issued by Chief Administrative Law Judge Stephen J. McGuire on October 17, 2005, and announced by...
The Federal Trade Commission today accepted for public comment an order resolving the competitive issues raised by DaVita, Inc.’s (DaVita) proposed $3.1 billion purchase of rival outpatient dialysis clinic operator Gambro Healthcare Inc. (Gambro) from Gambro AB. Pursuant to the order that will be...
The consent order resolves the competitive issues raised by DaVita’s proposed $3.1 billion purchase of rival outpatient dialysis clinic operator Gambro Healthcare Inc. from Gambro AB. Pursuant to the order, DaVita sold 69 dialysis clinics and end two management services contracts in...
Commission approval of petition to reopen and modify order: The Commission has approved a petition to reopen and modify a final order in the matter concerning White Sands Health Care System, L.L.C., Alamogordo Physician Cooperative, Inc., Dacite, Inc., and James R. Laurenza. The matter concerns...
The Federal Trade Commission today issued a report entitled “Pharmacy Benefit Managers: Ownership of Mail-Order Pharmacies.” The report, developed in response to a Congressional request in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), examines whether private-...
Commission approval of proposed divestiture: The Commission approved an application for proposed divestiture by Cemex, S.A. de C.V. (Cemex) related to its recent acquisition of RMC Group PLC (RMC). Under the terms of the consent order allowing the acquisition, Cemex was required to divest RMC’s...
Partners Health Network, Inc., a physician-hospital organization (PHO) operating in northwestern South Carolina, has agreed to settle Federal Trade Commission charges that it orchestrated and carried out agreements among its physician members to set the prices they would accept from health plans,...
A physician-hospital organization operating in northwestern South Carolina, agreed to settle charges that it orchestrated and carried out agreements among its physician members to set the prices they would accept from health plans, and to refuse to deal with health plans that did not...
Preserving competition in U.S. markets for three generic pharmaceuticals, the Federal Trade Commission today approved Novartis AG’s (Novartis) $1.72 billion acquisition of Eon Labs, Inc. (Eon), provided Novartis divests three overlapping drugs to Amide Pharmaceutical, Inc. (Amide).
To resolve competitive concerns for three generic pharmaceuticals that arose from Novartis AG’s acquisition of Eon Labs, Inc., Novartis agreed to divest all the assets necessary to manufacture and market generic desipramine hydrochloride tablets, orphenadrine citrate extended release...
Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter concerning San Juan IPA, Inc. The Commission vote approving issuance of the final consent order was 4-0-1, with Chairman Deborah Platt Majoras not...
Commission authorization of the staff to file amended complaint: The Commission has authorized the staff to file an amended complaint in the matter currently pending against Cleverlink Trading Limited, Real World Media, Brian D. Muir, Jesse Goldberg, and Caleb Wolf Wickman. The Commission’s...
Federal Trade Commission Principal Deputy General Counsel John Graubert today presented the Commission’s testimony on new entry into hospital competition before the U.S. Senate’s Subcommittee on Financial Management, Government Information, and International Security of the Committee on Homeland...
Petition requesting Commission approval of agreement amendments: The Commission has received a petition from the Dow Chemical Corporation (Dow) requesting approval of certain amendments to the “Ineos Agreement,” which is incorporated into the decision and order allowing the 2001 merger of Dow and...

Pages